| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2004 | CN1160056C Intravaginal clindamycin ovule composition |
| 08/04/2004 | CN1160053C Niacinamide compsns. with reduced tack |
| 08/04/2004 | CN1160052C Amino substituted hydroxy-diphenylone as light stability ultraviolet fitering agent used in cosmetic and pharmaceutical preparation |
| 08/04/2004 | CN1159985C Fibre blend for intestinal absorption composition |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770787 Heavier halogen atom substituted squaraine based dyes, process for the preparation thereof and use thereof as sensitizers for photodynamic, therapeutical and industrial applications |
| 08/03/2004 | US6770784 Reducing appetite |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770768 Lowers ldl cholesterol levels in serum and which is fat soluble beta - sitostanol fatty acid ester, and to a method for preparing and using the same. the substance can be taken orally as a food additive, food substitute or supplement. |
| 08/03/2004 | US6770759 Cephalosporins for treating a beta -lactam resistant bacterial infection in a mammal; enzyme inhibitors |
| 08/03/2004 | US6770750 Nucleotide sequences coding polypeptide for use and treatment of microorganismal infections |
| 08/03/2004 | US6770729 Implantable medical device with a polymer coating of 50 mol% of a diisocyanate, a hydrophilic polymer diol and/or diamine, a bioactive agent and a chain extender for controlled release |
| 08/03/2004 | US6770678 Warming (methylsulfonyl substituted-)-benzoylguanidine salt solution to accelerate dissolution; filtration, high speed freeze drying |
| 08/03/2004 | US6770675 Compositions and methods for reducing ocular hypertension |
| 08/03/2004 | US6770673 Administering dimethylaminoarglabin or salt as antitumor agent |
| 08/03/2004 | US6770670 Injectable composition |
| 08/03/2004 | US6770669 Amidine derivatives, preparation and use thereof as medicines |
| 08/03/2004 | US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770664 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/03/2004 | US6770663 Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds |
| 08/03/2004 | US6770661 Aryl substituted pyridines and their use |
| 08/03/2004 | US6770660 Method for inhibiting platelet aggregation |
| 08/03/2004 | US6770658 Substituted γ-phenyl-Δ-lactams and uses related thereto |
| 08/03/2004 | US6770657 Compounds |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770655 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome. |
| 08/03/2004 | US6770654 Indole derivatives and use thereof in medicines |
| 08/03/2004 | US6770653 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770649 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/03/2004 | US6770646 Substituted fused pyridazinone compounds; composition and use thereof |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770642 For use in treatment of cns disorders such as anxiety, depression, epilepsy, obsessive compulsive disorder, attention deficit disorder, migraine, cognitive memory enhancement, alzheimer's disease |
| 08/03/2004 | US6770641 Fused heteroaryl derivatives |
| 08/03/2004 | US6770638 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770635 Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions |
| 08/03/2004 | US6770634 Stimulate mammalian coronary vasodilatation for therapeutic purposes and imaging the heart |
| 08/03/2004 | US6770629 Polymerase inhibitor; anticancer agent |
| 08/03/2004 | US6770628 Hematopoietic stimulation |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770449 Methods of assaying receptor activity and constructs useful in such methods |
| 08/03/2004 | US6770444 Methods of identifying or screening for agents that binds the Ob-Re |
| 08/03/2004 | US6770307 Plant extract for diabetic therapy |
| 08/03/2004 | US6770306 Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 08/03/2004 | US6770305 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring |
| 08/03/2004 | US6770304 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 08/03/2004 | US6770300 Rapidly decomposing chitosan-based pellets |
| 08/03/2004 | US6770299 Lipid matrix-drug conjugates particle for controlled release of active ingredient |
| 08/03/2004 | US6770296 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins |
| 08/03/2004 | US6770295 Once-daily administration form, while maintaining the desired effect on the bladder, indeed gives a significant reduction of the (already low) side-effects, particularly dry mouth |
| 08/03/2004 | US6770292 Pharmaceutical compositions for oral administration |
| 08/03/2004 | US6770290 Amphotericin b liposomes formed have markedly reduced toxicity |
| 08/03/2004 | US6770271 Polyester polyurethanes, process for preparing them, pseudolatices produced from the said polyester polyurethanes and their use in cosmetic compositions |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | US6770263 Compositions and methods for the treatment of aches and pains |
| 08/03/2004 | US6770262 Intranasally administering metoclopramide or its salt for therapy or reducing the symptoms of gastroparesis in a patient |
| 08/03/2004 | US6770260 Mammal model contains a decreased level of endogenous macrophages sufficient to reduce depletion of non-autologous hematopoietic cells, achieved by administering an effective amount of dichloromethylene diphosphonate |
| 08/03/2004 | US6770148 Peritoneal dialysis solution containing modified icodextrins |
| 08/03/2004 | CA2456035A1 Use of n-ary n-arylmethyleneiminodiacetates or n, n1-diarylmethylene ethylenediamineacetates as sources of no lmethylene ethylenediaminetriacetates |
| 08/03/2004 | CA2456031A1 Use of mono- or di-esters of cinnamic acid or one of its derivatives and vitamin c, as a source of no |
| 08/03/2004 | CA2322173C Method for producing a fat mixture |
| 08/03/2004 | CA2310207C Topical zinc compositions and methods of use |
| 08/03/2004 | CA2294716C Method for drying anhydrous paroxetine hydrochloride |
| 08/03/2004 | CA2271095C Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation |
| 08/03/2004 | CA2270386C Process for substituted pyridines |
| 08/03/2004 | CA2147753C Tropone-substituted phenyloxazolidinone antibacterial agents |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 08/03/2004 | CA2133079C Oxazolidinone antimicrobials containing substituted diazine moieties |
| 08/03/2004 | CA2127542C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 08/03/2004 | CA2125001C Process for converting loracarbef dihydrate to loracarbef monohydrate |
| 08/03/2004 | CA2121065C External anti-inflammatory and analgesic plaster preparation |
| 08/03/2004 | CA2110161C Medetomidine preparations for transdermal administration |
| 08/03/2004 | CA2070230C Crystalline oxathiolane derivatives |
| 08/03/2004 | CA2058768C Treatment and control of ocular development |
| 07/31/2004 | CA2417943A1 Weight gain and growth stimulation in mammals by n-acylated glucosamines |
| 07/29/2004 | WO2004063388A2 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 07/29/2004 | WO2004063377A1 Drug screening method, recombinant vector, transformant and therapeutic composition for disease caused by apicomplexan parasite |
| 07/29/2004 | WO2004063365A1 NOVEL USE OF COMPOUND HAVING TGFβ-INHIBITORY ACTIVITY |
| 07/29/2004 | WO2004063348A2 Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators |
| 07/29/2004 | WO2004063345A2 Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators |
| 07/29/2004 | WO2004063336A2 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 07/29/2004 | WO2004063330A2 (2-carboxamido) (3-amino) thiophene compounds |
| 07/29/2004 | WO2004063211A1 Carbohydrate derivatives of paclitaxel and docetaxel, method for producing same and use thereof |
| 07/29/2004 | WO2004063210A1 Novel anticonvulsant derivative salts |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063201A1 Therapeutic agent for schizophrenia |
| 07/29/2004 | WO2004063200A1 Porphyrin derivatives |
| 07/29/2004 | WO2004063198A1 Diazepinoindole derivatives as kinase inhibitors |
| 07/29/2004 | WO2004063188A1 Paharmaceutical process and compounds prepared thereby |
| 07/29/2004 | WO2004063177A1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/29/2004 | WO2004063172A1 Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents |
| 07/29/2004 | WO2004063171A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 07/29/2004 | WO2004063167A1 Blood-brain barrier disruption inhibitors |
| 07/29/2004 | WO2004063160A1 Novel quaternary ammonium salt compound having antibacterial activity and process for producing the same |
| 07/29/2004 | WO2004063157A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |